Stock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets

Stock Track10-29

Shares of GeneDx Holdings (WGS) surged 5.11% in intraday trading on Wednesday, following a series of positive analyst actions. The genetic testing company saw its stock price climb as several prominent Wall Street firms raised their price targets, signaling increased confidence in the company's prospects.

Leading the bullish sentiment, BTIG reaffirmed its "Buy" rating on GeneDx Holdings while raising its price target to $165 from $140. This move was echoed by TD Cowen, which also increased its target to $165 from $140. Not to be left behind, Jefferies raised its price target to $150 from $120, further bolstering investor optimism.

The wave of analyst upgrades suggests growing confidence in GeneDx Holdings' business model and future growth potential. While specific reasons for the raised targets were not immediately available, such actions often reflect analysts' positive outlook on a company's financial performance, market position, or industry trends. Investors appear to be responding favorably to these endorsements, driving the stock's significant intraday gains.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122858501?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-29 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122858501","market":"hk","top_or_hot":-1,"title":"Stock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets","media":"Stock Track","content":"<p>Shares of GeneDx Holdings (WGS) surged 5.11% in intraday trading on Wednesday, following a series of positive analyst actions. The genetic testing company saw its stock price climb as several prominent Wall Street firms raised their price targets, signaling increased confidence in the company's prospects.</p>\n\n<p>Leading the bullish sentiment, BTIG reaffirmed its \"Buy\" rating on GeneDx Holdings while raising its price target to $165 from $140. This move was echoed by TD Cowen, which also increased its target to $165 from $140. Not to be left behind, Jefferies raised its price target to $150 from $120, further bolstering investor optimism.</p>\n\n<p>The wave of analyst upgrades suggests growing confidence in GeneDx Holdings' business model and future growth potential. While specific reasons for the raised targets were not immediately available, such actions often reflect analysts' positive outlook on a company's financial performance, market position, or industry trends. Investors appear to be responding favorably to these endorsements, driving the stock's significant intraday gains.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-29 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of GeneDx Holdings (WGS) surged 5.11% in intraday trading on Wednesday, following a series of positive analyst actions. The genetic testing company saw its stock price climb as several prominent Wall Street firms raised their price targets, signaling increased confidence in the company's prospects.</p>\n\n<p>Leading the bullish sentiment, BTIG reaffirmed its \"Buy\" rating on GeneDx Holdings while raising its price target to $165 from $140. This move was echoed by TD Cowen, which also increased its target to $165 from $140. Not to be left behind, Jefferies raised its price target to $150 from $120, further bolstering investor optimism.</p>\n\n<p>The wave of analyst upgrades suggests growing confidence in GeneDx Holdings' business model and future growth potential. While specific reasons for the raised targets were not immediately available, such actions often reflect analysts' positive outlook on a company's financial performance, market position, or industry trends. Investors appear to be responding favorably to these endorsements, driving the stock's significant intraday gains.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WGS","symbol_name":"GeneDx Holdings","start_time":0,"source_url":"","article_id":"1122858501","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122858501","pubTimestamp":1761750215,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of GeneDx Holdings (WGS) surged 5.11% in intraday trading on Wednesday, following a series of positive analyst actions. The genetic testing company saw its stock price climb as several...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WGS":"GeneDx Holdings"},"translate_title":"个股追踪|GeneDx Holdings大涨5.11%多位分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WGS":1},"content_text":"Shares of GeneDx Holdings (WGS) surged 5.11% in intraday trading on Wednesday, following a series of positive analyst actions. The genetic testing company saw its stock price climb as several prominent Wall Street firms raised their price targets, signaling increased confidence in the company's prospects.\nLeading the bullish sentiment, BTIG reaffirmed its \"Buy\" rating on GeneDx Holdings while raising its price target to $165 from $140. This move was echoed by TD Cowen, which also increased its target to $165 from $140. Not to be left behind, Jefferies raised its price target to $150 from $120, further bolstering investor optimism.\nThe wave of analyst upgrades suggests growing confidence in GeneDx Holdings' business model and future growth potential. While specific reasons for the raised targets were not immediately available, such actions often reflect analysts' positive outlook on a company's financial performance, market position, or industry trends. Investors appear to be responding favorably to these endorsements, driving the stock's significant intraday gains.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122858501","isCrawlerRequest":true}